Skip to content

Recognized Experts in ADME / DMPK / DDI by 98% of top pharma & countless others for drug metabolism and drug-drug interaction expertise.

Learn More
1

Webinar: Design Intricacies and Decision-Making Strategy for DDI Studies

Hear drug-drug interaction (DDI) expert, Dr. Andrew G. Taylor, discuss how to avoid common pitfalls by tweaking ADME/DDI strategies to...

Webinar: New 2022 Draft ICH Drug Interaction Studies Global Guideline

Presenter: Brian Ogilvie, Ph.D, Vice President of Scientific Consulting at XenoTech Drug-drug interactions (DDI) may occur when taking two (or...

XenoTech Joins BioIVT: Expands Biospecimens Portfolio and Research Services

BioIVT, a leading provider of research models, biospecimens and research services for drug discovery and development has acquired XenoTech Along...

Great reports that are ready for submission to the Agency!

Pharma Senior Vice President of R&D

Every XenoTech employee I had contact with throughout these studies have been a pleasure to work with. The entire process was seamless. I never had...

Regulatory Affairs for Small Pharma

There is a lot of quality, skilled work that has gone into this data set. Compared to organizations that have done this type of work...

ADME Consultant

Great reports that are ready for submission to the Agency!

Pharma Senior Vice President of R&D

Every XenoTech employee I had contact with throughout these studies have been a pleasure...

Regulatory Affairs for Small Pharma

There is a lot of quality, skilled work that has gone into this data...

ADME Consultant

Your drug’s journey…

Your drug’s journey…

057 liver and stomach Created with Sketch.

through the body

through the pipeline

Absorption, Distribution, Metabolism, and Excretion (ADME) properties of a xenobiotic describe its disposition and inform overall fate following administration. XenoTech serves 98% of top pharma and countless others by providing high-quality contracted ADME studies and test systems to precede or support clinical trials.

Drug Metabolism & Pharmacokinetics (DMPK) is a core discipline in drug discovery and development investigating how a drug is broken down and cleared, considering both ADME and DDI characteristics to evaluate and optimize properties of a new drug compound. Our drug metabolism and pharmacokinetics testing and products allows sponsors to understand properties of their compounds and to evaluate risk early in drug development and testing.

Drug-Drug Interaction (DDI) studies allow a drug developer to investigate the potential of a xenobiotic compound to interact with drug-metabolizing enzymes and drug transporters to predict the impact on the pharmacokinetics of the compound or coadministered drugs. Drug metabolism and drug transporter studies provide critical information in evaluating potential for drug-drug interactions and associated risks in preclinical drug development.